The secretory small GTPase Rab27B as a marker for breast cancer progression.
In contemporary oncology practice, an urgent need remains to refine the prognostic assessment of breast cancer. It is still difficult to identify patients with early breast cancer who are likely to benefit from adjuvant chemotherapy. Although invasion of cancer cells is the main prognostic denominat...
| Autor principal: | |
|---|---|
| Outros Autores: | , , , , , |
| Formato: | article |
| Idioma: | eng |
| Publicado em: |
2022
|
| Assuntos: | |
| Texto completo: | http://hdl.handle.net/10362/145399 |
| País: | Portugal |
| Oai: | oai:run.unl.pt:10362/145399 |